tradingkey.logo

Sciwind Biosciences Announces Ecnoglutide Injection Approval By China's NMPA For Chronic Weight Management

ReutersMar 6, 2026 7:10 AM

- Sciwind Biosciences:

  • SCIWIND BIOSCIENCES ANNOUNCES ECNOGLUTIDE INJECTION APPROVED BY CHINA'S NATIONAL MEDICAL PRODUCTS ADMINISTRATION (NMPA) FOR CHRONIC WEIGHT MANAGEMENT

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI